Copyright: ©Author(s) 2026.
World J Diabetes. Aug 15, 2026; 17(8): 123389
Published online Aug 15, 2026. doi: 10.4239/wjd.123389
Published online Aug 15, 2026. doi: 10.4239/wjd.123389
Table 5 Multivariate regression analysis of risk determinants for osteoporosis in type 2 diabetes mellitus
| Variable | β | SE | Wald | P value | OR | 95%CI |
| Constant | -4.121 | 1.354 | 9.260 | 0.002 | 0.016 | |
| Age (years) | 0.040 | 0.018 | 5.061 | 0.024 | 1.040 | 1.005-1.077 |
| HbA1c (%) | 0.082 | 0.066 | 1.508 | 0.219 | 1.085 | 0.953-1.236 |
| PTH | 0.017 | 0.005 | 11.872 | 0.001 | 1.017 | 1.007-1.027 |
| β-CTX | 0.269 | 0.404 | 0.443 | 0.506 | 1.308 | 0.593-2.889 |
| Disease course (years) | -0.004 | 0.023 | 0.032 | 0.859 | 0.996 | 0.954-1.042 |
| Smoking history (0 = no, 1 = yes) | -0.201 | 0.480 | 0.176 | 0.675 | 0.818 | 0.319-2.094 |
- Citation: Lu HL, Yu F, Zhou HF, Hu P, Gan SL. Clinical significance of bone metabolic markers in osteoporosis-complicated type 2 diabetes mellitus and risk determinants: A retrospective study. World J Diabetes 2026; 17(8): 123389
- URL: https://www.wjgnet.com/1948-9358/full/v17/i8/123389.htm
- DOI: https://dx.doi.org/10.4239/wjd.123389